Prescription drug · ANDA
Gabarone (Gabapentin) NDC 74157-111
Gabapentin 400 mg/1 · Tablet · Oral · INA Pharmaceutics Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 74157-111-90 | 7415701119074157011190 | 90 TABLET in 1 BOTTLE (74157-111-90)Marketed from Dec 23, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Gabarone
- Generic name (nonproprietary)
- gabapentin
- Active ingredients
- Gabapentin — 400 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- INA Pharmaceutics Inc.NDC labeler code 74157
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 211313
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
- Identifiers
- Product ID 74157-111_47d9ab92-3736-01a7-e063-6394a90a7c55SPL ID 47d9ab92-3736-01a7-e063-6394a90a7c55SPL set ID 0f350a4b-f294-4b98-b69f-3cc789e930baRxCUI 476673, 476679, 602399, 602407UNII 6CW7F3G59XUPC 0374157013900, 0374157111903
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N474157011190followed by a unit qualifier and the quantityPackage 74157-0111-90. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
GABARONE is indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy GABARONE is indicated for: Postherpetic neuralgia in adults (1) Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy (1)
Excerpt only. Read the full label for complete information.
About NDC 74157-111
- What is NDC 74157-111?
- 74157-111 is the product NDC for Gabarone (gabapentin), Gabapentin 400 mg/1 tablet, listed with the FDA by INA Pharmaceutics Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Gabarone (Gabapentin).
- What is the active ingredient?
- Gabapentin.
- Who is the labeler?
- INA Pharmaceutics Inc., NDC labeler code 74157. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Gabarone?
- 1 other product NDC are listed under this name. See all Gabarone NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Gabarone products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Gabaronegabapentin | Gabapentin 100 mg/1 | TabletOral | INA Pharmaceutics Inc. | 74157-013 | 74157-0013-90 |
Other NDCs under ANDA 211313
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Gabaronegabapentin | Gabapentin 100 mg/1 | TabletOral | INA Pharmaceutics Inc. | 74157-013 |